These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5096690)

  • 1. [Naphthydrofuryl in neurology].
    Ahumada BH
    Prensa Med Argent; 1971 Jul; 58(21):1067-70. PubMed ID: 5096690
    [No Abstract]   [Full Text] [Related]  

  • 2. [Angiodilatator therapy in otology: value of Praxilene].
    Bordes LR; Baradat P; Lienhart H; Debrie JC
    Rev Laryngol Otol Rhinol (Bord); 1971; 92(11):858-63. PubMed ID: 5151167
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of primary and secondary Raynaud's syndrome using naftidrofuryl (Dusodril)].
    Kriessmann A; Sauer E
    Dtsch Med J; 1971 Dec; 22(23):743-5. PubMed ID: 5135008
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes of lower leg blood circulation during oral therapy with naftidrofuryl (dusodril)].
    Kriessmann A; Rädler M
    Munch Med Wochenschr; 1973 Mar; 115(12):508-10. PubMed ID: 4739661
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experience with the new vasoactivator Dusodril. Results of clinical tests and a double-blind experiment].
    Bötticher R; Raithel D
    Med Klin; 1971 Nov; 66(46):1571-3. PubMed ID: 4944892
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vasodilator agents in peripheral arterial occlusive disease with coronary insufficiency, myocardial infarct and pacemakers. Electrocardiographic studies in intravenous naftidrofuryl-infusion].
    Heidrich H; Wehselau H
    Med Welt; 1974 Jul; 25(26):1161-3. PubMed ID: 4845152
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experiences with naftidrofuryl in peripheral arterial occlusive diseases].
    Hauch E; Lévai Z
    Med Welt; 1973 Oct; 24(43):1665-6. PubMed ID: 4764064
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of functional changes in arteriosclerotic chronic obliterating peripheral arterial diseases (COPA) and Buerger's and Raynaud's diseases with pharmacological sympathicolysis, with or without indirect surgical treatment].
    Bagliani A; Borri P; Taborelli R
    Minerva Cardioangiol; 1973 Jun; 21(6):439-52. PubMed ID: 4720185
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic results in peripheral and cerebrovascular blood circulation disorders following the administration of Dusodril].
    Kaufmann J; Förster W
    Z Allgemeinmed; 1970 May; 46(13):688-9. PubMed ID: 5522940
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new peripheral vasodilator agent. Personal experience with naphtidrofuryl].
    Romero RL; Vives C; Pastor C; Valdivia Velarde H; Basso G; Bordone JC
    Prensa Med Argent; 1970 May; 57(11):537-42. PubMed ID: 5454084
    [No Abstract]   [Full Text] [Related]  

  • 11. [Value of vasodilator agents in neuropsychiatric practice and study of the indications for Praxilene].
    Bornstein S; Sère de Rivières H
    Therapeutique; 1972 Jan; 48(1):27-34. PubMed ID: 5046366
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasodilators.
    Judge TG
    Practitioner; 1974 Oct; 213(1276 SPEC NO):467-9. PubMed ID: 4156401
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical trials of Praxilene in a neurosurgical department].
    Chodkiewicz JP; Visot A; Rivierez M; Conegero E
    Therapeutique; 1973 Nov; 49(9):567-76. PubMed ID: 4600035
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of arterial occlusive diseases with Dusodril].
    Fortschr Med; 1974 Jul; 92(20):873-4. PubMed ID: 4411256
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of (naphthyl 1)-3 tetrahydrofuryl-2 propionate of diethylamino 2 ethyl on arteries of medium and small calibre. Analysis executed on first and second derivative of peripheral segmental plethysmogram studied in subjects affected by sclerotic obliterating arterial disease].
    Tardito E; Azzolini A; Agus GB; Grassi T
    Minerva Cardioangiol; 1973 Sep; 21(9):573-80. PubMed ID: 4745000
    [No Abstract]   [Full Text] [Related]  

  • 16. Double-blind trial of naftidrofuryl in the treatment of cerebral arteriosclerosis.
    Gerin J
    Br J Clin Pract; 1974 May; 28(5):177-8. PubMed ID: 4604345
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nafditrofuryl and carotid spasms].
    Fournier AM; Mourou M; Chiousse E
    J Radiol Electrol Med Nucl; 1972 Dec; 53(12):897. PubMed ID: 4653459
    [No Abstract]   [Full Text] [Related]  

  • 18. [Naftidrofuryl in venous pathology].
    Milleret PG
    Phlebologie; 1970; 23(2):189-91. PubMed ID: 5448640
    [No Abstract]   [Full Text] [Related]  

  • 19. [Naftidrofuryl, a new blood vessel-active substance in the preparation for arterial vascular surgery].
    Becker HM
    Med Klin; 1970 Feb; 65(8):359-61. PubMed ID: 5519232
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison between xenon 133 and thermography in experimental study of a vasodilator agent].
    Beurey J; Weber M; Saussure M; Bertrand A; Robert J
    Bull Soc Fr Dermatol Syphiligr; 1972; 79(1):68-70. PubMed ID: 4565812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.